AstraZeneca News

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources said.

's stock had its "neutral" rating reaffirmed by JP Morgan Cazenove in a research note issued on Monday, ARN reports.

's stock had its "hold" rating reiterated by equities research analysts at Panmure Gordon in a research note issued to investors on Monday, AnalystRatingsNetwork.com reports.

Approximately 25 million Americans suffer from asthma, which accounts for more than 3300 deaths each year.

's stock had its "neutral" rating reiterated by equities research analysts at JP Morgan Cazenove in a research note issued to investors on Tuesday, AnalystRatingsNetwork.com reports.

Shares of AstraZeneca traded down 0.08% during mid-day trading on Wednesday, hitting $51.54. AstraZeneca has a 52 week low of $39.72 and a 52 week high of $52.27. The stock's 50-day moving average is currently $50.92. The company has a market cap of $64.425 billion and a P/E ratio of 11.41. Other equities research analysts have also recently issued ... (more)

Pozen's "nightmare" partnership is changing its terms, but what that might mean for the Chapel Hill company remains unclear.

's stock had its "equal weight" rating restated by equities researchers at Morgan Stanley in a report issued on Wednesday, Analyst Ratings Network reports.

VIVUS, Inc. Announces Richard Fante , Former President U.S. and CEO North America, AstraZeneca PLC , to Serve as Senior Advisor Staying up-to-date has never been simpler.

The Supreme Court on April 12 upheld two high court rulings that said the state and the Japanese unit of British drug maker AstraZeneca PLC bore no liability for fatal side effects caused by the lung cancer drug Iressa.

Bristol-Myers Squibb Company , AstraZeneca PLC Release: Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients With Lipodystrophy During a 12-Month Period Staying up-to-date has never been simpler.

's stock had its "hold" rating reaffirmed by research analysts at Jefferies Group in a report released on Thursday, StockRatingsNetwork reports.

's stock had its "neutral" rating reiterated by equities research analysts at JP Morgan Cazenove in a research note issued to investors on Thursday, ARN reports.

A.P. Pharma, Inc. , a specialty pharmaceutical company, today announced that its Board of Directors has appointed a new management team to lead the Company.

's stock had its "hold" rating reaffirmed by research analysts at Jefferies International in a report released on Thursday, StocKRatingsNetwork.com reports.

Major drug manufacturers have reported their financial results for the first quarter during the latest earnings season.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Union leaders will meet executives at AstraZeneca today to try to convince Britain's second-biggest drugmaker to reverse plans to close its R&D site in Cheshire and move almost 2,000 jobs.

Moderna Therapeutics has tapped Henri Termeer , the former chairman, president and CEO of Genzyme Corp.

's stock had its "neutral" rating reiterated by investment analysts at Goldman Sachs in a note issued to investors on Monday, Analyst Ratings Network reports.

's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday, Analyst Ratings.Net reports.